Ayala Pharmaceuticals
Biotechnology; Pharmaceutical
Ayala Pharmaceuticals has raised €27M across 1 funding round from 1 investor, most recently a Series B round in Apr 2019. Based in Tel Aviv, Israel; founded 2017. Data as of 4 Nov 2026.
Total raised
€27M
€26,702,270
Funding rounds
1
Investors
1
distinct backers
Active since
2019-04
latest 2019-04
Funding by year
EUR raised per yearAyala Pharmaceuticals — funding by year — interactive chart.
Data table
| Ayala Pharmaceuticals — funding by year | |
|---|---|
| 2019 | €27M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Series B | €27M | Novartis Venture Fund | View deal → |